These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7127663

  • 1. Absence of antitumor activity of ORG 5895, a 11 beta-aziridinylmethyl derivative of estradiol, on the MXT mammary tumor and the P388 leukemia.
    Devleeschouwer N, Leclercq G, Danguy A, Atassi G.
    Cancer Chemother Pharmacol; 1982; 8(3):315-6. PubMed ID: 7127663
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.
    Narita T, Yaguchi S, Komatsu T, Takase M, Hoshino A, Inaba M, Tsukagoshi S.
    Cancer Chemother Pharmacol; 1990; 26(3):193-7. PubMed ID: 2357766
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.
    Marsh JC, Shoemaker RH, Suffness M.
    Cancer Treat Rep; 1985 Jun; 69(6):683-5. PubMed ID: 4016772
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and antileukemic activity of fluorinated analogues of 2,3-dihydro-5-phenyl-6,7-bis(hydroxymethyl)-1H-pyrrolizine biscarbamate.
    Anderson WK, McPherson HL.
    J Med Chem; 1982 Jan; 25(1):84-6. PubMed ID: 7086826
    [No Abstract] [Full Text] [Related]

  • 11. Preclinical antitumor activity of batracylin (NSC 320846).
    Plowman J, Paull KD, Atassi G, Harrison SD, Dykes DJ, Kabbe HJ, Narayanan VL, Yoder OC.
    Invest New Drugs; 1988 Sep; 6(3):147-53. PubMed ID: 3192381
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative antineoplastic activity against P388 leukemia of 9-beta-D-arabinofuranosyladenine (araA) and 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl) adenine (arazide).
    Lee SH, Thomas LK, Unger FM, Christian R, Sartorelli AC.
    Int J Cancer; 1981 May 15; 27(5):703-8. PubMed ID: 6974703
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect.
    Köpf-Maier P, Wagner W, Hesse B, Köpf H.
    Eur J Cancer (1965); 1981 Jun 15; 17(6):665-9. PubMed ID: 7308264
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
    Hisamatsu T, Suzuki K, Sakakibara S, Komuro K, Nagasawa M, Takeuchi T, Umezawa H.
    Jpn J Cancer Res; 1985 Oct 15; 76(10):1008-20. PubMed ID: 3935619
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC, Schurig JE, Huftalen JB, Bradner WT.
    Cancer Res; 1983 Apr 15; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract] [Full Text] [Related]

  • 20. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF, Muggia FM, Johnson RK.
    Cancer Treat Rep; 1979 Apr 15; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.